These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

452 related items for PubMed ID: 15650310

  • 21. [Sublingual immunotherapy in children with grass pollen induced allergic rhinoconjunctivitis].
    Wolthers OD, Høst A, Frederiksen B, Halken S.
    Ugeskr Laeger; 2012 Aug 27; 174(35):1989-92. PubMed ID: 22929576
    [Abstract] [Full Text] [Related]

  • 22. Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation.
    Suárez-Fueyo A, Ramos T, Galán A, Jimeno L, Wurtzen PA, Marin A, de Frutos C, Blanco C, Carrera AC, Barber D, Varona R.
    J Allergy Clin Immunol; 2014 Jan 27; 133(1):130-8.e1-2. PubMed ID: 24290282
    [Abstract] [Full Text] [Related]

  • 23. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
    Cosmi L, Santarlasci V, Angeli R, Liotta F, Maggi L, Frosali F, Rossi O, Falagiani P, Riva G, Romagnani S, Annunziato F, Maggi E.
    Clin Exp Allergy; 2006 Mar 27; 36(3):261-72. PubMed ID: 16499636
    [Abstract] [Full Text] [Related]

  • 24. Heterogeneity of antibody responses among clinical responders during grass pollen sublingual immunotherapy.
    Baron-Bodo V, Horiot S, Lautrette A, Chabre H, Drucbert AS, Danzé PM, Sénéchal H, Peltre G, Galvain S, Zeldin RK, Horak F, Moingeon P.
    Clin Exp Allergy; 2013 Dec 27; 43(12):1362-73. PubMed ID: 24261946
    [Abstract] [Full Text] [Related]

  • 25. Effect of AIT in children including potential to prevent the development of asthma.
    Valovirta E.
    Allergy; 2011 Jul 27; 66 Suppl 95():53-4. PubMed ID: 21668856
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Allergen-specific immunotherapy with recombinant grass pollen allergens.
    Jutel M, Jaeger L, Suck R, Meyer H, Fiebig H, Cromwell O.
    J Allergy Clin Immunol; 2005 Sep 27; 116(3):608-13. PubMed ID: 16159631
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Efficacy and tolerability of high dose sublingual immunotherapy in patients with rhinoconjunctivitis.
    Worm M.
    Eur Ann Allergy Clin Immunol; 2006 Dec 27; 38(10):355-60. PubMed ID: 17274520
    [Abstract] [Full Text] [Related]

  • 31. Rush immunotherapy with sublingual administration of grass allergen extract.
    Feliziani V, Marfisi RM, Parmiani S.
    Allergol Immunopathol (Madr); 1993 Dec 27; 21(5):173-8. PubMed ID: 8160561
    [Abstract] [Full Text] [Related]

  • 32. Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis.
    Didier A, Malling HJ, Worm M, Horak F, Sussman G, Melac M, Soulié S, Zeldin RK.
    Clin Exp Allergy; 2013 May 27; 43(5):568-77. PubMed ID: 23600548
    [Abstract] [Full Text] [Related]

  • 33. Allergy immunotherapy tablet: Grazax® for the treatment of grass pollen allergy.
    Senna GE, Calderon M, Milani M.
    Expert Rev Clin Immunol; 2011 Jan 27; 7(1):21-7. PubMed ID: 21162646
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
    Rossi RE, Monasterolo G, Coco G, Silvestro L, Operti D.
    Vaccine; 2007 Jan 15; 25(5):957-64. PubMed ID: 17045368
    [Abstract] [Full Text] [Related]

  • 35. Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study.
    Hordijk GJ, Antvelink JB, Luwema RA.
    Allergol Immunopathol (Madr); 1998 Jan 15; 26(5):234-40. PubMed ID: 9885731
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Safety and immunological changes during sublingual immunotherapy with standardized quality grass allergen tablets.
    Malling HJ, Lund L, Ipsen H, Poulsen L.
    J Investig Allergol Clin Immunol; 2006 Jan 15; 16(3):162-8. PubMed ID: 16784009
    [Abstract] [Full Text] [Related]

  • 38. Specific immunotherapy for allergic rhinitis to grass and tree pollens in daily medical practice-symptom load with sublingual immunotherapy compared to subcutaneous immunotherapy.
    Sieber J, Shah-Hosseini K, Mösges R.
    Ann Med; 2011 Jan 15; 43(6):418-24. PubMed ID: 21679103
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study.
    Ott H, Sieber J, Brehler R, Fölster-Holst R, Kapp A, Klimek L, Pfaar O, Merk H.
    Allergy; 2009 Jan 15; 64(1):179-86. PubMed ID: 19076534
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.